Krishnan Suma

President, R&D, Director, 10% OwnerKrystal Biotech, Inc. (KRYS) · full profile →Form 4 · filed Jun 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7.7M
Net Open-Market Flow
-$7.7M
Transactions
11
11 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 4, 2026Sell(S)320$300.75$96K1.4M
Jun 4, 2026Sell(S)593$302.25$179K1.4M
Jun 4, 2026Sell(S)247$303.17$75K1.4M
Jun 4, 2026Sell(S)400$304.89$122K1.4M
Jun 4, 2026Sell(S)480$305.87$147K1.4M
Jun 4, 2026Sell(S)1K$307.09$414K1.4M
Jun 4, 2026Sell(S)13K$307.81$3.9M1.4M
Jun 4, 2026Sell(S)4K$308.89$1.2M1.4M
Jun 4, 2026Sell(S)3K$309.95$868K1.4M
Jun 4, 2026Sell(S)2K$310.94$634K1.4M
Jun 4, 2026Sell(S)240$311.65$75K1.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001298711-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly: